NCT06389617View on ClinicalTrials.gov

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 30, 2024

Conditions
End Stage Renal Failure
Interventions
DRUG

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

All Listed Sponsors
lead

Hospital Universiti Sains Malaysia

OTHER

NCT06389617 - Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block | Biotech Hunter | Biotech Hunter